Shaolin Capital Management’s Envoy Medical Warrant COCHW Stock Holding History

Shaolin Capital Management’s Portfolio COCHW Stock Details COCHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100,000	Closed	-$5K	–	280
2024 Q2	$5K	Buy	+100,000	New	+$10.9K	﹤0.01%	317
2024 Q1	–	Sell	-159,979	Closed	-$3.2K	–	371
2023 Q4	$3.2K	Sell	159,979 -48,599	-23%	-$1.31K	﹤0.01%	416
2023 Q3	$19K	Hold	208,578	–	–	﹤0.01%	410
2023 Q2	$10K	Hold	208,578	–	–	﹤0.01%	548
2023 Q1	$8K	Hold	208,578	–	–	﹤0.01%	647
2022 Q4	$8K	Hold	208,578	–	–	﹤0.01%	678
2022 Q3	$14K	Buy	208,578 +42,753	+26%	+$3.87K	﹤0.01%	775
2022 Q2	$21K	Buy	+165,825	New	+$35.5K	﹤0.01%	830

Other funds holding COCHW

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Shaolin Capital Management's COCHW Position: Q3 2024 in Review

Shaolin Capital Management sold out of Envoy Medical Warrant (COCHW) in Q3 2024, closing a stake of 100,000 shares — an estimated $5K sold.

Shaolin Capital Management first reported a position in COCHW in Q2 2022 and held it in 8 quarters. The position peaked at $21K in Q2 2022. 41 funds tracked by Wall St. Rank hold COCHW as of Q3 2024.

Shaolin Capital Management reported no remaining Envoy Medical Warrant position as of Q3 2024 after selling out during the quarter.
Shaolin Capital Management sold 100,000 Envoy Medical Warrant shares in Q3 2024, an estimated $5K.
Shaolin Capital Management first reported a position in Envoy Medical Warrant in Q2 2022 and held it in 8 quarters.
Shaolin Capital Management's Envoy Medical Warrant position peaked at $21K in Q2 2022.
41 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q3 2024.

Based on Shaolin Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.